Celltrion Healthcare, Stock Price Down 1.2% at This Hour... 899,461 Shares Sold Net by Individuals in Last 5 Days

As of 9:30 AM on the 3rd, Celltrion Healthcare is trading at 148,800 KRW, down 1.2% from the previous day. The trading volume is 433,002 shares, which is about 19.24% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

On January 29, Minjeong Seon, a researcher at Hana Financial Investment, stated, "A decline in Truxima sales to the U.S. is expected in 2021. However, sales estimates for new products could exceed expectations, so Celltrion Healthcare’s estimates may be revised upward after quarterly earnings announcements. Additionally, if the COVID-19 treatment Regkirona receives EUA approval from the U.S. FDA, high growth similar to that of 2020 is expected to continue in 2021." She set the target price for Celltrion Healthcare at 175,000 KRW.

Over the past five days, individual investors have net sold 899,461 shares of Celltrion Healthcare, while foreign investors and institutions have net bought 795,795 shares and 115,696 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.